Most companies talk about being data-driven. Flo Health runs approximately 400 concurrent A/B tests at any given time and executes over 1,000 experiments annually. This experimentation culture has driven the world’s most downloaded women’s health app to serve 420 million users.
The scale of testing reflects engineering philosophy. The femtech unicorn releases software daily—a pace that would terrify most companies handling sensitive health data. But this speed enables rapid learning. One onboarding experiment alone increased trial conversions eightfold.
Experimentation extends to new features. The launch of perimenopause capabilities involved extensive testing before rollout. The perimenopause tracking features were refined through data analysis to ensure they delivered genuine value to users navigating this life stage.
What’s remarkable is that this experimentation culture survived regulatory transformation. When the company built FDA-ready infrastructure in 87 days, the explicit goal was maintaining innovation speed. Engineers working under Quality Management System processes report no decrease in velocity or satisfaction.
For digital health companies worried that compliance means stagnation, the message is clear: 1,000+ annual experiments can coexist with regulatory readiness if you build the infrastructure right.